FEBS Journal-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2019-12-20 alizee

是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表::
8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表:
8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？

189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？

148 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2016-06-14 wutongshu

投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，

446 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-11-16 灿烂千阳

审稿速度:1.0
经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-04-15 这是一个昵称

欧洲生化协会的会刊，类似FASEB，对机制有要求

187 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-03-23 那个unique的明天

浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表:
试试吧，我不太了解你说的这个方向，反正挺快的是真的

脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的

145 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-03-17 脉脉如烟

试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表:
请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗

156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗

162 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-03-09 __未知元素

你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表:
老哥，我也是啊，你后来怎么样了

惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了

140 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-22 147f9deem35暂无昵称

请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗

148 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-22 147f9deem35暂无昵称

请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表:
12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快

脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快

144 0

[GetPortalCommentsPageByObjectIdResponse(id=581905, encodeId=717c58190524, content=是在审稿了我之前也是这个状态变成的major revision189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？189****5216 2019-09-07 00:00:00 发表: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, beContent=189****5216 2019-09-07 发表:: 8月12号投出去的，一周左右变成waiting referee assignment.，这个状态持续到现在，这个实在审稿中的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zM2dfibOKfu6TcNKwLTcgiakVxmHU1wJBlcTX5Adr8U9xdo0Yl2ITNEh8UoSlJgKI5cffEicCTX0Dd0fOTBswvvwQ/132, createdBy=7afe5185484, createdName=alizee, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523574, encodeId=2db35235e4d1, content=投稿当天awaiting referee selection, 然后是爱waiting editor in chief, 以为要拒稿了，结果后面状态改为awaiting referee assignment, awaiting referee scores, 现在一直还是这个状态，大概持续了一周多了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84a498358, createdName=wutongshu, createdTime=Tue Jun 14 16:21:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899660, encodeId=108c899660b7, content=审稿速度:1.0 经验分享：一审大修，但Editor-in-Chief提到所有补充材料的图都要放在正文里，只有视频或者大数据集等可放补充材料。不知道这个是硬性要求还是编辑的建议。补充图挺多的，放正文的话要全文大改。有经验的小伙伴可否指点指点，谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5dHsQxzwZ6Q1vsiaCTmNR6AMIB51Sgh4jNrmuynsEAvJe7p3FTUW6kLibPJSQZAhaXPcojVovMMHAucvYzPdJ7rA/132, createdBy=f9411984072, createdName=灿烂千阳, createdTime=Mon Nov 16 19:32:31 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588964, encodeId=c48858896454, content=欧洲生化协会的会刊，类似FASEB，对机制有要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/2d0413f4fd3b4a5f1acc9ccc7d585f61.jpg, createdBy=b9cb2546102, createdName=这是一个昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587243, encodeId=31cc58e243e1, content=浏览了一下文章涉及酶结构方面的文章居多，是否主要以蛋白结构方向为主呢？谢谢！脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, beContent=脉脉如烟 2020-03-17 00:00:00 发表: 试试吧，我不太了解你说的这个方向，反正挺快的是真的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bd15311687, createdName=那个unique的明天, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586814, encodeId=dbe9586814b1, content=试试吧，我不太了解你说的这个方向，反正挺快的是真的156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, beContent=156****1335暂无昵称 2020-02-22 00:00:00 发表: 请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3f22248078, createdName=脉脉如烟, createdTime=Tue Mar 17 00:00:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586246, encodeId=b0e658624645, content=你好，我也是投稿3天变成这状态，请问后来怎么样了呢？惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, beContent=惨的一笔 2018-08-02 00:00:00 发表: 老哥，我也是啊，你后来怎么样了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/EaOYlUibSwic93UaRwibVRUa3iaHo7iaepkibshWM1FmbFcq5AdujaYBkUDGdoLCTmuiaf8d5ukI9Y4RtHaxc90YIvogw/132, createdBy=41272289783, createdName=__未知元素, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585174, encodeId=ec0c5851e469, content=请问中过的大佬，杂志对文章创新性要求高吗，干细胞分子生物学基础实验可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585175, encodeId=4c055851e531, content=请问杂志对文章研究内容有偏好吗，干细胞分子生物学基础的可以吗脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, beContent=脉脉如烟 2020-01-15 00:00:00 发表: 12月11号投，一月14号接收，速度非常快，特别推荐着急的同仁试一试，不行还能试lett，也很快, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584497, encodeId=d02b58449e26, content=我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, beContent=135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20192100429, createdName=1891f66399m, createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-10 1891f66399m

我是with editor 8-9天，awaiting，editor in chief 持续2天返回小修135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表:
一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急

135vElE9445(暂无昵称) 2020-01-14 00:00:00 发表: 一审修回10天了，in review 的状态只显示了一天，然后就一直是awaiting editor in chief ，想问这个状态需要多久？很急

127 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务